{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:42:53Z","timestamp":1784932973484,"version":"3.55.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/23744235.2021.1963469","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T15:44:32Z","timestamp":1632498272000},"page":"16-25","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiology and antibiotic susceptibility in anaerobic bacteraemia: a 15-year retrospective study in South-Eastern Hungary"],"prefix":"10.1080","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-0918","authenticated-orcid":false,"given":"K\u00e1roly P\u00e9ter","family":"S\u00e1rv\u00e1ri","sequence":"first","affiliation":[{"name":"Institute of Clinical Microbiology, University of Szeged, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra Bernadett","family":"R\u00e1cz","sequence":"additional","affiliation":[{"name":"Institute of Clinical Microbiology, University of Szeged, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Buri\u00e1n","sequence":"additional","affiliation":[{"name":"Institute of Clinical Microbiology, University of Szeged, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01407.x"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2397-7"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12195"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.Supplement_1.S97"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/16.Supplement_4.S288"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.5.1038"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2016.02.009"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.4.633"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1086\/512197"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00635-17"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa039"},{"key":"CIT0012","unstructured":"Public Health England. 2014. UK standards for microbiology investigations B 37: investigation of blood cultures (for organisms other thanMycobacteriumspecies). Available from: http:\/\/www.gov.uk\/government\/collections\/standards-for-microbiology-investigations-smi."},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12180"},{"key":"CIT0015","unstructured":"Centers for Disease Control and Prevention (CDC). Collecting cultures: a clinician guide. Available from: https:\/\/www.cdc.gov\/antibiotic-use\/core-elements\/collecting-cultures.html."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.4217"},{"key":"CIT0017","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical Breakpoints V.8.1. 2018. Available from: https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"CIT0018","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 28th informational supplement. CLSI document M100-S23. Wayne, PA: CLSI, 2018. Available from: https:\/\/file.qums.ac.ir\/repository\/mmrc\/CLSI-2018-M100-S28.pdf."},{"key":"CIT0019","unstructured":"Tigecycline: The US FDA susceptibility breakpoint to tigecycline for anaerobes is set 17 at 4\u2009mg\/L. US FDA. FDA Approved Drug Products Label for TYGACIL, NDA no. 18 021821 (approved 23 5 2013). Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021821s037lbl.pdf. (13 July 2013, date last accessed)."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.5799\/jmid.493845"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2016.48.2.91"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.11.2391"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2013.03.001"},{"issue":"1","key":"CIT0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.47102\/annals-acadmedsg.V44N1p13","volume":"44","author":"Ng L SY","year":"2015","journal-title":"Ann Acad Med Singap"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01464.x"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.6.1492"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Teng JC, Dreyer LL. Antimicrobial susceptibility patterns of anaerobic bacteria in Victoria, Australia. bioRxiv 2018. DOI:10.1101\/308023","DOI":"10.1101\/308023"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.03.030"}],"container-title":["Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/23744235.2021.1963469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T02:46:49Z","timestamp":1673318809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/23744235.2021.1963469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/23744235.2021.1963469"],"URL":"https:\/\/doi.org\/10.1080\/23744235.2021.1963469","relation":{},"ISSN":["2374-4235","2374-4243"],"issn-type":[{"value":"2374-4235","type":"print"},{"value":"2374-4243","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=infd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=infd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}